Cargando…

COVID-19 vaccine safety inquiries to the centers for disease control and prevention immunization safety office

BACKGROUND: Following the authorization and recommendations for use of the U.S. COVID-19 vaccines, the Centers for Disease Control and Prevention (CDC)’s Immunization Safety Office (ISO) responded to inquiries and questions from public health officials, healthcare providers, and the general public o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miller, Elaine R., Moro, Pedro L., Shimabukuro, Tom T., Carlock, Grace, Davis, Shaeyla N., Freeborn, Emma M., Roberts, Amy L., Gee, Julianne, Taylor, Allan W., Gallego, Ruth, Suragh, Tiffany, Su, John R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2023
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208263/ https://www.ncbi.nlm.nih.gov/pubmed/37248099 http://dx.doi.org/10.1016/j.vaccine.2023.05.054

Ejemplares similares

Safety Monitoring of an Additional Dose of COVID-19 Vaccine — United States, August 12–September 19, 2021
por: Hause, Anne M., et al.
Publicado: (2021)

Safety in the Dental Office
por: Rafetto, Louis K.
Publicado: (2023)

Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine — United States, March–April 2021
por: Shay, David K., et al.
Publicado: (2021)

COVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021
por: Hause, Anne M., et al.
Publicado: (2021)

Safety Training Course: Territorial Safety Officer (TSO)
por: Balle, Christoph
Publicado: (2015)

Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5–11 Years — United States, May 17–July 31, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5–11 Years — United States, October 12–January 1, 2023
por: Hause, Anne M., et al.
Publicado: (2023)

Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons
por: Shimabukuro, Tom T., et al.
Publicado: (2021)

U.S. Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines
por: Gubernot, Diane, et al.
Publicado: (2021)

COVID-19 mRNA Vaccine Safety Among Children Aged 6 Months–5 Years — United States, June 18, 2022–August 21, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

Quadrivalent HPV vaccine safety review and safety monitoring plans for nine-valent HPV vaccine in the United States
por: Gee, Julianne, et al.
Publicado: (2016)

Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12–17 Years — United States, December 9, 2021–February 20, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

COVID-19 Vaccine Safety in Adolescents Aged 12–17 Years — United States, December 14, 2020–July 16, 2021
por: Hause, Anne M., et al.
Publicado: (2021)

Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults — United States, September 22, 2021–February 6, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years — United States, August 31–October 23, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

UK COVID-19 public inquiry and lessons from patient safety
por: Whitaker, David K
Publicado: (2021)

Quality and Safety—The View from the Corner Office
por: Allen, Steve
Publicado: (2016)

Safety Training Course: Territorial Safety Officer (TSO) - Refresher, EN Department
por: Balle, Christoph
Publicado: (2017)

Notes from the Field: Safety Monitoring of Novavax COVID-19 Vaccine Among Persons Aged ≥12 Years — United States, July 13, 2022–March 13, 2023
por: Romanson, Brittney, et al.
Publicado: (2023)

Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status — United States, January 12, 2022–March 28, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

Occupational Safety of Municipal Police Officers: Assessing the Vulnerability and Riskiness of Police Officers’ Work
por: Soltes, Viktor, et al.
Publicado: (2021)

Factors influencing patient safety in Sweden: perceptions of patient safety officers in the county councils
por: Nygren, Mikaela, et al.
Publicado: (2013)

Job description for the PS division radiation safety officer
por: Chohan, V
Publicado: (1998)

Medication safety officer preparatory course: Outcomes and experiences
por: Aljadhey, Hisham, et al.
Publicado: (2017)

Survey of the necessary competencies and proficiency of safety officers in Thailand
por: ISHIMARU, Tomohiro, et al.
Publicado: (2020)

Via media: Role and responsibilities of the independent safety officer
por: Holbein, M. E. B., et al.
Publicado: (2019)

Conceptions of inquiry
por: Brown, Stuart, et al.
Publicado: (1981)

Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged ≥50 Years — United States, March 29, 2022–July 10, 2022
por: Hause, Anne M., et al.
Publicado: (2022)

First Month of COVID-19 Vaccine Safety Monitoring — United States, December 14, 2020–January 13, 2021
por: Gee, Julianne, et al.
Publicado: (2021)

The v-safe after vaccination health checker: Active vaccine safety monitoring during CDC’s COVID-19 pandemic response
por: Myers, Tanya R., et al.
Publicado: (2023)

Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe
por: Rosenblum, Hannah G, et al.
Publicado: (2022)

Incident safety officer: a training program for fire departments
por: Haberer, Jo Ann B
Publicado: (1996)

Effect of an Office-Based Surgical Safety System on Patient Outcomes
por: Rosenberg, Noah M., et al.
Publicado: (2012)

The safety of in‐office laryngologic procedures during active antithrombotic therapy
por: Straub, Jeffrey M., et al.
Publicado: (2020)

Office Anesthesia in Dentistry:: Assuring Safety While Reducing Anxiety
por: Rafetto, Alexandra, et al.
Publicado: (2018)

Systematic review of the safety and efficacy of tramadol during office hysteroscopy
por: Maarouf, Hiba, et al.
Publicado: (2021)

Evaluation of Pharmacy Inquiries in Physician Order Reviews for Medication Safety: A Cross-Sectional Study
por: Cho, Jungwon, et al.
Publicado: (2022)

An Inquiry, Critical and Experimental, Etc.
por: Davis, N. S.
Publicado: (1853)

PhD-Prepared Nurses' Areas of Inquiry
por: Roberts, Lisa R., et al.
Publicado: (2023)

Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination — Five U.S. Mass Vaccination Sites, April 2021
por: Hause, Anne M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_04m6u88utjgtco25jv9jq5k9f3